JPH07267985A - Production of tauroursodeoxycholic acid hydrate - Google Patents

Production of tauroursodeoxycholic acid hydrate

Info

Publication number
JPH07267985A
JPH07267985A JP6309894A JP6309894A JPH07267985A JP H07267985 A JPH07267985 A JP H07267985A JP 6309894 A JP6309894 A JP 6309894A JP 6309894 A JP6309894 A JP 6309894A JP H07267985 A JPH07267985 A JP H07267985A
Authority
JP
Japan
Prior art keywords
acid
tauroursodeoxycholic
tauroursodeoxycholic acid
organic solvent
aqueous solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP6309894A
Other languages
Japanese (ja)
Inventor
Kazutoshi Mikami
一利 三上
Noriyuki Kimura
憲行 木村
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tokyo Tanabe Co Ltd
Original Assignee
Tokyo Tanabe Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tokyo Tanabe Co Ltd filed Critical Tokyo Tanabe Co Ltd
Priority to JP6309894A priority Critical patent/JPH07267985A/en
Publication of JPH07267985A publication Critical patent/JPH07267985A/en
Pending legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

PURPOSE:To simply obtain a tauroursodeoxycholic acid hydrate from an aqueous solution of tauroursodeoxycholic acid on an industrial scale at a low cost without using an organic solvent. CONSTITUTION:This method for producing a tauroursodeoxycholic acid hydrate is to condense taurine with ursodeoxycholic acid in an organic solvent, then distill away the organic solvent, add an acid such as dilute sulfuric acid or dilute hydrochloric acid to the resultant aqueous solution of the tauroursodeoxycholic acid, deposit a crystal of the tauroursodeoxycholic acid hydrate and wash the formed crystal thereof with water.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は血中脂質低下作用などの
有効な薬理作用を示すタウロウルソデオキシコール酸水
和物の製法に関する。
FIELD OF THE INVENTION The present invention relates to a method for producing tauroursodeoxycholic acid hydrate which exhibits an effective pharmacological action such as a hypolipidemic action in blood.

【0002】[0002]

【従来の技術】タウロウルソデオキシコール酸1gは1
mlに容易に溶解し、きわめて水に溶け易いことから、
水溶液中から直接結晶として効率よくかつ純度よく取り
出すのは非常に困難である。タウロウルソデオキシコー
ル酸水和物の製法に関しては、特開昭63−14689
5号公報、特開平3−17096号公報の記載の方法が
ある。いずれも反応によって生じる無機塩及び未反応の
タウリンをろ過することにより除去した後、大量の有機
溶媒によってタウロウルソデオキシコール酸を析出させ
る方法である。
2. Description of the Related Art 1 g of tauroursodeoxycholic acid is 1
It easily dissolves in ml and is extremely soluble in water,
It is very difficult to extract crystals directly from an aqueous solution efficiently and with high purity. Regarding the method for producing tauroursodeoxycholic acid hydrate, see JP-A 63-14689.
5 and JP-A-3-17096. Both are methods in which inorganic salts generated by the reaction and unreacted taurine are removed by filtration, and then tauroursodeoxycholic acid is precipitated with a large amount of an organic solvent.

【0003】[0003]

【発明が解決しようとする課題】上記の方法の問題点と
しては、(1)有機溶媒を使用して無機塩を取り除く操
作を繰り返すため、操作が煩雑であり、反応により生ず
る無機塩並びに未反応のタウリン及びウルソデオキシコ
ール酸を完全に除去することが困難であること、(2)
多量の有機溶媒を必要とし工業的な実施が困難であるこ
と、(3)タウリンとウルソデオキシコール酸との縮合
反応後の減圧乾固は、操作上の危険を伴うことが挙げら
れる。
The problem with the above method is that (1) the operation of removing the inorganic salt using an organic solvent is repeated, so the operation is complicated, and the inorganic salt produced by the reaction and unreacted It is difficult to completely remove the taurine and ursodeoxycholic acid from (2)
It requires a large amount of organic solvent and is difficult to carry out industrially. (3) Drying under reduced pressure after the condensation reaction of taurine and ursodeoxycholic acid is dangerous in operation.

【0004】発明者等は、これら問題点を解決すべく鋭
意研究した結果、タウロウルソデオキシコール酸水溶液
から有機溶媒を使用せず、タウロウルソデオキシコール
酸水和物が工業的規模で安価かつ簡便に得られる本製法
を発明するに至った。
As a result of intensive studies to solve these problems, the inventors have found that tauroursodeoxycholic acid hydrate is inexpensive and convenient on an industrial scale without using an organic solvent from an aqueous solution of tauroursodeoxycholic acid. The present invention has been invented.

【0005】[0005]

【課題を解決するための手段】本発明によれば、タウロ
ウルソデオキシコール酸の製法において、(1)水を含
んでも良い有機溶媒中、タウリンとウルソデオキシコー
ル酸とを脱水縮合反応に付す工程、(2)有機溶媒を留
去して得られる水溶液を洗浄して未反応のウルソデオキ
シコール酸を除去する工程、(3)タウロウルソデオキ
シコール酸の水溶液に酸を添加することによりpHを調
整してタウロウルソデオキシコール酸水和物を晶出させ
る工程からなるタウロウルソデオキシコール酸水和物の
製法が提供される。
According to the present invention, in the method for producing tauroursodeoxycholic acid, (1) a step of subjecting taurine and ursodeoxycholic acid to a dehydration condensation reaction in an organic solvent which may contain water. , (2) a step of washing the aqueous solution obtained by distilling off the organic solvent to remove unreacted ursodeoxycholic acid, (3) adjusting the pH by adding an acid to the aqueous solution of tauroursodeoxycholic acid There is provided a method for producing tauroursodeoxycholic acid hydrate, which comprises a step of crystallizing tauroursodeoxycholic acid hydrate.

【0006】本発明において、脱水縮合反応は混合酸無
水物法、活性エステル法等の通常のペプチド合成に使用
される方法が使用できる(泉屋ら、「ペプチド合成」、
丸善株式会社、1975年)。脱水縮合反応に使用され
る溶媒としては、脱水縮合反応を阻害しないものであれ
ば、いずれの溶媒も使用でき、例えば、n−ヘキサン、
ベンゼン等の炭化水素、ジクロルメタン、クロロホルム
等のハロゲン化炭化水素、ジエチルエーテル、1,2−
ジメトキシエタン等の鎖状エーテル類、ジオキサン、テ
トラヒドロフラン等の環状エーテル類、酢酸エチル、酢
酸ブチル等のエステル類が挙げられる。脱水縮合剤とし
ては、混合酸無水物法においては、クロル炭酸エチル、
クロル炭酸イソブチル等の炭酸モノアルキルエステル等
が挙げられ、活性エステル法においては、p−ニトロフ
ェニルエステル、クロロ化フェニルエステル、2−エト
キシ−1−(2H)−キノリンカルボン酸エステル等が
挙げられる。反応は無水条件でも含水条件でも行える
が、無水条件で行った場合には、反応終了後、水を添加
すれば良い。
In the present invention, the dehydration condensation reaction can be carried out by a method commonly used for peptide synthesis such as a mixed acid anhydride method or an active ester method (Izumiya et al., "Peptide Synthesis",
Maruzen Co., Ltd., 1975). As the solvent used in the dehydration condensation reaction, any solvent can be used as long as it does not inhibit the dehydration condensation reaction, and for example, n-hexane,
Hydrocarbons such as benzene, halogenated hydrocarbons such as dichloromethane, chloroform, diethyl ether, 1,2-
Examples thereof include chain ethers such as dimethoxyethane, cyclic ethers such as dioxane and tetrahydrofuran, and esters such as ethyl acetate and butyl acetate. As the dehydration condensing agent, in the mixed acid anhydride method, ethyl chlorocarbonate,
Examples thereof include carbonic acid monoalkyl esters such as isobutyl chlorocarbonate, and p-nitrophenyl ester, chlorinated phenyl ester, 2-ethoxy-1- (2H) -quinolinecarboxylic acid ester and the like in the active ester method. The reaction can be carried out under anhydrous condition or under water containing condition, but when carried out under anhydrous condition, water may be added after completion of the reaction.

【0007】pH調整に使用される酸は、特に限定され
るものではないが、例えば、塩酸、硫酸等の鉱酸が挙げ
られる。pHは酸性、好ましくは3以下である。
The acid used for pH adjustment is not particularly limited, but examples thereof include mineral acids such as hydrochloric acid and sulfuric acid. The pH is acidic, preferably 3 or less.

【0008】ウルソデオキシコール酸の除去の有機溶媒
は水と混和しにくく、かつウルソデオキシコール酸を溶
解するものであれば良く、例えば、n−ヘキサン、ベン
ゼン等の炭化水素、ジクロルメタン、クロロホルム等の
ハロゲン化炭化水素、ジエチルエーテル、ジイソプロピ
ル等のエーテル類、酢酸エチル、酢酸ブチル等のエステ
ル類が挙げられる。
The organic solvent for removing ursodeoxycholic acid may be any solvent that is not miscible with water and dissolves ursodeoxycholic acid. For example, hydrocarbons such as n-hexane, benzene, etc., dichloromethane, chloroform, etc. Examples thereof include halogenated hydrocarbons, ethers such as diethyl ether and diisopropyl, and esters such as ethyl acetate and butyl acetate.

【0009】また、本法によれば、粗製のタウロウルソ
デオキシコール酸を精製することもできる。すなわち、
粗製タウロウルソデオキシコール酸を水に溶解し得られ
る水溶液からウルソデオキシコール酸を有機溶媒により
除去し、タウロウルソデオキシコール酸の水溶液とし、
これに酸を添加することにより、タウロウルソデオキシ
コール酸水和物を晶析させる精製法である。
According to this method, crude tauroursodeoxycholic acid can also be purified. That is,
Crude tauroursodeoxycholic acid is dissolved in water to remove the ursodeoxycholic acid from the resulting aqueous solution with an organic solvent to obtain an aqueous solution of tauroursodeoxycholic acid.
This is a purification method in which an acid is added to this to crystallize tauroursodeoxycholic acid hydrate.

【0010】[0010]

【実施例】以下、本発明の方法について代表的な実施例
を示す。以下の実施例においては、本製法における主な
不純物である無機塩またはタウリンの含有率を第十二改
正日本薬局方記載の硫酸塩試験法を準用して測定した。
タウロウルソデオキシコール酸の純度を、薄層板として
Kieselgel 60F254(商標:メルク社
製)を、展開溶媒としてクロロホルム:エタノール:酢
酸エチル:酢酸:水(8:6:5:4:1)の混合溶媒
を用いた薄層クロマトグラフィーにより測定した。
EXAMPLES Representative examples of the method of the present invention will be shown below. In the following examples, the content of inorganic salts or taurine, which are the main impurities in this production method, was measured by applying the sulfate test method described in the 12th revised Japanese Pharmacopoeia.
The purity of tauroursodeoxycholic acid was obtained by mixing Kieselgel 60F254 (trademark: manufactured by Merck) as a thin plate and chloroform: ethanol: ethyl acetate: acetic acid: water (8: 6: 5: 4: 1) as a developing solvent. It was measured by thin layer chromatography using a solvent.

【0011】(実施例1)ウルソデオキシコール酸(2
5g)をジオキサン(250ml)に溶解し、トリエチ
ルアミン(10.2ml,1.15当量)を加え攪拌し
た。混合液を10°まで冷却し、クロル炭酸エチル
(7.0ml,1.15当量)を滴下した。次いでタウ
リン(9.17g,1.15当量)の1規定水酸化ナト
リウム溶液(66ml)を滴下した。反応液を1時間攪
拌後、減圧蒸留してジオキサンを留去した。残分に水を
加え水溶液とし希塩酸でpH6に調整の後、酢酸エチル
で未反応のウルソデオキシコール酸を除去した。更に減
圧濃縮した後、希塩酸を加えpH1に調整し、そのまま
室温で2時間攪拌することによって結晶を析出させた。
析出した結晶を濾過、水洗後、乾燥してタウロウルソデ
オキシコール酸水和物(27.9g)を得た。収率は8
1.9%であった。無機塩及びタウリンの含有率はそれ
ぞれ0.1%以下であり、タウロウルソデオキシコール
酸の純度は99.9%以上であった。
(Example 1) Ursodeoxycholic acid (2
5 g) was dissolved in dioxane (250 ml), triethylamine (10.2 ml, 1.15 equivalents) was added, and the mixture was stirred. The mixture was cooled to 10 ° and ethyl chlorocarbonate (7.0 ml, 1.15 eq) was added dropwise. Then, 1N sodium hydroxide solution (66 ml) of taurine (9.17 g, 1.15 equivalent) was added dropwise. The reaction solution was stirred for 1 hour and then distilled under reduced pressure to remove dioxane. Water was added to the residue to make an aqueous solution, and the pH was adjusted to 6 with dilute hydrochloric acid, and then unreacted ursodeoxycholic acid was removed with ethyl acetate. After further concentration under reduced pressure, diluted hydrochloric acid was added to adjust the pH to 1, and the mixture was stirred at room temperature for 2 hours to precipitate crystals.
The precipitated crystals were filtered, washed with water and dried to obtain tauroursodeoxycholic acid hydrate (27.9 g). Yield 8
It was 1.9%. The content of each of the inorganic salt and taurine was 0.1% or less, and the purity of tauroursodeoxycholic acid was 99.9% or more.

【0012】得られた結晶は、融点141〜149°、
2%水溶液のpH1.5、溶解度は30.5°におい
て、2.22%(w/w)を示した。
The obtained crystals have a melting point of 141 to 149 °,
The pH of a 2% aqueous solution was 1.5, and the solubility was 2.25% (w / w) at 30.5 °.

【0013】(実施例2)ウルソデオキシコール酸(1
0g)を酢酸エチル(100ml)に溶解し、トリエチ
ルアミン(4.08ml,1.15当量)を加え攪拌し
た。混合液を10°まで冷却し、クロル炭酸エチル
(2.8ml,1.15当量)を滴下した。次いでタウ
リン(3.67g,1.15当量)の1規定水酸化ナト
リウム溶液(27ml)を滴下した。反応液を1時間攪
拌後、希硫酸でpH5に調整の後、分液した。水層を酢
酸エチルで洗浄し、未反応のウルソデオキシコール酸を
除去した。更に減圧濃縮した後、希硫酸を加えpH2に
調整し、そのまま室温で2時間攪拌することによって結
晶を析出させた。析出した結晶を濾過、水洗後、乾燥し
てタウロウルソデオキシコール酸水和物(11.0g)
を得た。収率は80.6%であった。無機塩及びタウリ
ンの含有率はそれぞれ0.1%以下であり、タウロウル
ソデオキシコール酸の純度は99.9%以上であった。
(Example 2) Ursodeoxycholic acid (1
0 g) was dissolved in ethyl acetate (100 ml), triethylamine (4.08 ml, 1.15 equivalent) was added, and the mixture was stirred. The mixture was cooled to 10 ° and ethyl chlorocarbonate (2.8ml, 1.15eq) was added dropwise. Then, 1N sodium hydroxide solution (27 ml) of taurine (3.67 g, 1.15 equivalent) was added dropwise. The reaction solution was stirred for 1 hour, adjusted to pH 5 with diluted sulfuric acid, and then separated. The aqueous layer was washed with ethyl acetate to remove unreacted ursodeoxycholic acid. After further concentration under reduced pressure, dilute sulfuric acid was added to adjust the pH to 2, and the mixture was stirred at room temperature for 2 hours to precipitate crystals. The precipitated crystals were filtered, washed with water, dried and then tauroursodeoxycholic acid hydrate (11.0 g)
Got The yield was 80.6%. The content of each of the inorganic salt and taurine was 0.1% or less, and the purity of tauroursodeoxycholic acid was 99.9% or more.

【0014】(実施例3)ウルソデオキシコール酸(2
5g)を酢酸エチル(250ml)に溶解し、トリエチ
ルアミン(10.2ml,1.15当量)を加え攪拌し
た。混合液を10°まで冷却し、クロル炭酸エチル
(7.0ml,1.15当量)を滴下した。次いでタウ
リン(9.17g,1.15当量)を1規定水酸化ナト
リウム(66ml)溶液を滴下した。反応液を1時間攪
拌後、希硫酸でpH5に調整の後、分液した。水層を酢
酸エチルで洗浄し、未反応のウルソデオキシコール酸を
除去した。更に減圧濃縮した後、希硫酸を加えpH3に
調整し、そのまま室温で2時間攪拌することによって結
晶を析出させた。析出した結晶を濾過、水洗後、乾燥し
てタウロウルソデオキシコール酸水和物(26.0g)
を得た。収率は76.3%であった。無機塩及びタウリ
ンの含有率はそれぞれ0.1%以下であり、タウロウル
ソデオキシコール酸の純度は99.9%以上であった。
(Example 3) Ursodeoxycholic acid (2
5 g) was dissolved in ethyl acetate (250 ml), triethylamine (10.2 ml, 1.15 equivalent) was added, and the mixture was stirred. The mixture was cooled to 10 ° and ethyl chlorocarbonate (7.0 ml, 1.15 eq) was added dropwise. Then, taurine (9.17 g, 1.15 equivalents) was added dropwise to a 1N sodium hydroxide (66 ml) solution. The reaction solution was stirred for 1 hour, adjusted to pH 5 with diluted sulfuric acid, and then separated. The aqueous layer was washed with ethyl acetate to remove unreacted ursodeoxycholic acid. After further concentration under reduced pressure, diluted sulfuric acid was added to adjust the pH to 3, and the mixture was stirred at room temperature for 2 hours to precipitate crystals. The precipitated crystals were filtered, washed with water, dried and then tauroursodeoxycholic acid hydrate (26.0 g)
Got The yield was 76.3%. The content of each of the inorganic salt and taurine was 0.1% or less, and the purity of tauroursodeoxycholic acid was 99.9% or more.

【0015】(実施例4)ウルソデオキシコール酸(2
0g)を酢酸エチル(200ml)に溶解し、トリエチ
ルアミン(8.16ml,1.15当量)を加え攪拌し
た。混合液を10°まで冷却し、クロル炭酸エチル
(5.6ml,1.15当量)を滴下した。次いでタウ
リン(7.34g,1.15当量)を1規定水酸化ナト
リウム(53ml)溶液を滴下した。反応液を1時間攪
拌後、希硫酸でpH4に調整の後、分液した。水層をそ
の後酢酸エチルで洗浄し、未反応のウルソデオキシコー
ル酸を除去した。更に減圧濃縮して、希硫酸を加えpH
1に調整し、そのまま室温で2時間攪拌することによっ
て結晶を析出させた。析出した結晶を濾過、水洗後、乾
燥してタウロウルソデオキシコール酸水和物(22.6
g)を得た。収率は82.7%であった。無機塩及びタ
ウリンの含有率はそれぞれ0.1%以下であり、タウロ
ウルソデオキシコール酸の純度は99.9%以上であっ
た。
(Example 4) Ursodeoxycholic acid (2
0 g) was dissolved in ethyl acetate (200 ml), triethylamine (8.16 ml, 1.15 equivalents) was added, and the mixture was stirred. The mixture was cooled to 10 ° and ethyl chlorocarbonate (5.6 ml, 1.15 eq) was added dropwise. Next, taurine (7.34 g, 1.15 equivalents) was added dropwise to a 1N sodium hydroxide (53 ml) solution. The reaction solution was stirred for 1 hour, adjusted to pH 4 with diluted sulfuric acid, and then separated. The aqueous layer was then washed with ethyl acetate to remove unreacted ursodeoxycholic acid. Concentrate under reduced pressure and add diluted sulfuric acid to adjust pH.
The crystal was precipitated by adjusting to 1 and stirring at room temperature for 2 hours. The precipitated crystals were filtered, washed with water, dried and then tauroursodeoxycholic acid hydrate (22.6
g) was obtained. The yield was 82.7%. The content of each of the inorganic salt and taurine was 0.1% or less, and the purity of tauroursodeoxycholic acid was 99.9% or more.

Claims (3)

【特許請求の範囲】[Claims] 【請求項1】 タウロウルソデオキシコール酸の製法に
おいて、(1)水を含んでも良い有機溶媒中、タウリン
とウルソデオキシコール酸とを脱水縮合反応に付す工
程、(2)有機溶媒を留去して得られる水溶液を洗浄し
て未反応のウルソデオキシコール酸を除去する工程、
(3)タウロウルソデオキシコール酸の水溶液に酸を添
加することによりpHを調整してタウロウルソデオキシ
コール酸水和物を晶出させる工程からなるタウロウルソ
デオキシコール酸水和物結晶を得る方法。
1. In the method for producing tauroursodeoxycholic acid, (1) a step of subjecting taurine and ursodeoxycholic acid to a dehydration condensation reaction in an organic solvent which may contain water, and (2) distilling off the organic solvent. Washing the aqueous solution obtained by removing unreacted ursodeoxycholic acid,
(3) A method for obtaining tauroursodeoxycholic acid hydrate crystals, which comprises a step of crystallizing tauroursodeoxycholic acid hydrate by adjusting the pH by adding an acid to an aqueous solution of tauroursodeoxycholic acid.
【請求項2】 pHを3以下とする請求項1記載の方
法。
2. The method according to claim 1, wherein the pH is 3 or less.
【請求項3】 添加する酸が希硫酸、希塩酸である請求
項1または請求項2記載の方法。
3. The method according to claim 1, wherein the acid to be added is dilute sulfuric acid or dilute hydrochloric acid.
JP6309894A 1994-03-31 1994-03-31 Production of tauroursodeoxycholic acid hydrate Pending JPH07267985A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP6309894A JPH07267985A (en) 1994-03-31 1994-03-31 Production of tauroursodeoxycholic acid hydrate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6309894A JPH07267985A (en) 1994-03-31 1994-03-31 Production of tauroursodeoxycholic acid hydrate

Publications (1)

Publication Number Publication Date
JPH07267985A true JPH07267985A (en) 1995-10-17

Family

ID=13219492

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6309894A Pending JPH07267985A (en) 1994-03-31 1994-03-31 Production of tauroursodeoxycholic acid hydrate

Country Status (1)

Country Link
JP (1) JPH07267985A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100396113B1 (en) * 1996-10-14 2003-12-24 동아제약 주식회사 Method for purifying tauroursodeoxycholic acid
EP1985622A1 (en) * 2007-04-23 2008-10-29 Prodotti Chimici E Alimentari Spa Process for the preparation of tauroursodesoxycholic acid
CN111825737A (en) * 2019-04-16 2020-10-27 迪法玛弗朗西斯有限公司 Purification of cholanic acid conjugates

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100396113B1 (en) * 1996-10-14 2003-12-24 동아제약 주식회사 Method for purifying tauroursodeoxycholic acid
EP1985622A1 (en) * 2007-04-23 2008-10-29 Prodotti Chimici E Alimentari Spa Process for the preparation of tauroursodesoxycholic acid
WO2008128844A1 (en) * 2007-04-23 2008-10-30 Prodotti Chimici E Alimentari Spa Process for the preparation of tauroursodesoxycholic acid
CN111825737A (en) * 2019-04-16 2020-10-27 迪法玛弗朗西斯有限公司 Purification of cholanic acid conjugates

Similar Documents

Publication Publication Date Title
BR112019027323A2 (en) method for preparing 4-methoxypyrrole derivative intermediate
KR890000618B1 (en) Process for the preparation of salicylic derivatives of n-acetyl cysteine
JPH06234715A (en) Production of alanylglutamine
US4760164A (en) Process for producing α-L-aspartyl-L-phenylalanine methyl ester
JPH07267985A (en) Production of tauroursodeoxycholic acid hydrate
JPS63146895A (en) Synthesis of tauroylsodeoxycol acid
JP3291991B2 (en) Purification method of O, S-dimethyl N-acetyl phosphoramidothioate
JP3521242B2 (en) Purification method of biscresols
JPH0737440B2 (en) Method for producing sulfonium compound
JPH0411557B2 (en)
JP2001226372A (en) Crystalline and crystallizing or crystallized rosartan acid adduct and method of purification of rosartan
JP3291987B2 (en) Purification method of O, S-dimethyl-N-acetylphosphoramidothioate
JP2002114737A (en) METHOD FOR PRODUCING OPTICALLY ACTIVE o-CHLOROMANDELIC ACID
KR100396113B1 (en) Method for purifying tauroursodeoxycholic acid
JPH08157437A (en) Production of d-amino acid-n-(s)-alpha-alkylbenzylamide
JP4085199B2 (en) Method for producing O, O-dimethyl-O- (p-cyanophenyl) phosphorothioate
JP3316917B2 (en) New phenylalanine salt crystals and their production
BE901069A (en) PROCESS FOR THE SYNTHESIS OF URSODESOXYCHOLIC ACID CONJUGATED WITH TAURINE AND PRODUCT THUS OBTAINED.
JP2003096038A (en) Production method of high-purity n-long chain acylamino acid or salt thereof
JP4827364B2 (en) Method for purifying p-cyanophenol
JPS606699A (en) Purification of bile acid
JPS61172846A (en) Method of optical resolution of (+-)-2-chloroprorionic acid
KR20010023821A (en) Method of purifying and recovering sweetener
KR810001695B1 (en) Process for the preparation of terephthalamide derivatives
KR920000269B1 (en) Purification of n-benzoyl-l-aspartic acid

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20031225

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20050315